Controlled defibrination in the treatment of peripheral vascular disease.
D000721:Ancrod / Q000627:therapeutic use; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D001809:Blood Viscosity; D004195:Disease Models, Animal; D005337:Fibrin; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D013924:Thrombophlebitis / Q000503:physiopathology; D014652:Vascular Diseases / Q000097:blood / Q000188:drug therapy / Q000628:therapy*
D005338:Fibrin Fibrinogen Degradation Products; D005337:Fibrin; D005340:Fibrinogen; D000721:Ancrod